EVALUATION OF THE MARCH AND BALANCE BY MEANS OF INERTIAL SENSORS PRE AND POST NEUROMUSCULAR BLOCKING IN CHILDREN WITH SPASTIC BRAIN PARALYSIS

Abstract

CEREBRAL PALSY (CP) IS CURRENTLY INTERPRETED AS THE SET OF DISTURBANCES IN THE DEVELOPMENT OF MOVEMENTS AND POSTURES, WITH LIMITATION OF MOTOR ACTIVITY, ATTRIBUTED TO THE INADEQUATE DEVELOPMENT OF THE FETAL OR INFANT BRAIN, CAUSING CHRONIC PHYSICAL DISABILITIES, AS WELL AS DEFICIENCIES THAT LIMIT THE THE ACTIVITIES OF DAILY LIVING. TO THAT END, BOTULINUM TOXIN TYPE A (TBA) IS ONE OF THE TREATMENTS THAT ARE BEING STUDIED, AND IS PRODUCING SATISFACTORY AND SAFE RESULTS FOR SPASTICITY AND OTHER DISEASES DUE TO CP. THE PRESENT PROJECT AIMS TO VERIFY THE EFFECTS OF NEUROMUSCULAR BLOCKADE WITH BOTULINUM TOXIN ON THE GAIT AND BALANCE OF CHILDREN WITH SPASTIC CEREBRAL PALSY. THE POPULATION SAMPLE WILL BE DEFINED AFTER A PILOT STUDY, WITH THE SAME METHODOLOGY OF THE PROPOSED STUDY, WILL BE PART OF THIS PROJECT CHILDREN WITH CEREBRAL PALSY WITH COGNITIVE AGE OF 6 TO 14 CLASSIFIED BETWEEN LEVELS I, II AND III BY THE MOTOR FUNCTION CLASSIFICATION SYSTEM THICK - GMFCS. THE APPLICATION OF THE TBA WILL BE CARRIED OUT BY A SPECIALIZED PHYSICIAN OF THE REHABILITATION CENTER OF THE APAE, BEING USED THE ASHWORTH SCALE FOR THE DETERMINATION OF THE MUSCLES TO BE SUBMITTED TO THE NEUROMUSCULAR BLOCKADE. THE EVALUATIONS WILL BE IN 4 DISTINCT MOMENTS (PRE-BLOCK, 72, 1 MONTH AND 4 MONTHS AFTER THE APPLICATION OF THE TOXIN). THE EVALUATIONS WILL CONSIST OF A QUANTITATIVE ANALYSIS OF THE GAIT (WALK TEST); (TUG TEST) BOTH TESTS USING A PORTABLE G-SENSOR PORTABLE (BTS BIOENGINEERING G-STUDIO�®) INERTIAL SENSOR. THE RESULTS WILL BE ANALYZED STATISTICALLY ASSUMING A LEVEL OF SIGNIFICANCE OF P�‰¤0.05.